Stock PBH PRESTIGE CONSUMER HEALTHCARE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Prestige Consumer Healthcare Inc.

Equities

PBH

US74112D1019

Real-time Estimate Cboe BZX
Other stock markets
 10:27:32 2024-07-03 am EDT 		5-day change 1st Jan Change
68.19 USD -0.13% Intraday chart for Prestige Consumer Healthcare Inc. -1.02% +11.39%
Jun. 21 DA Davidson Upgrades Prestige Consumer Healthcare to Buy From Neutral, Adjusts Price Target to $93 From $65 MT
May. 15 Sector Update: Health Care Stocks Rise Pre-Bell Wednesday MT

Evolution of the average Target Price on Prestige Consumer Healthcare Inc.

Price target over the last 5 years

History of analyst recommendation changes

3d6ace2bfcc7b1a4a213e88bc9f63.fCnnFwEDVhnfcnvx0-6WrYeHiFD-4HiOz-ciTOHgR2I.HRy0c3MwGDS1Hk21qbn55OrM6QWKpDW8pqVDfYmmdC5LHaNUVWAgLegcKg~47f2e0116d655996a29e916de2e24d8d

Analyst Recommendations on Prestige Consumer Healthcare Inc.

DA Davidson Upgrades Prestige Consumer Healthcare to Buy From Neutral, Adjusts Price Target to $93 From $65 MT
Oppenheimer Adjusts Prestige Consumer Healthcare's Price Target to $71 From $72, Maintains Outperform Rating MT
Canaccord Genuity Starts Prestige Consumer Healthcare at Buy With $71 Price Target MT
Oppenheimer Adjusts Price Target on Prestige Consumer Healthcare to $63 From $68, Maintains Outperform Rating MT
Oppenheimer Adjusts Price Target on Prestige Consumer Healthcare to $68 From $63, Maintains Outperform Rating MT
ANALYST RECOMMENDATIONS : Edison International, Ford, General Motors, GSK, Upstart... Our Logo
Jefferies Upgrades Prestige Consumer Healthcare to Buy From Hold, Adjusts Price Target to $70 From $65 MT
DA Davidson Lowers Prestige Consumer Healthcare's Price Target to $60 From $63, Maintains Neutral Rating MT
Oppenheimer Upgrades Prestige Consumer Healthcare to Outperform From Perform, Sets $63 Price Target MT
DA Davidson Adjusts Price Target on Prestige Consumer Healthcare to $63 from $61, Keeps Neutral Rating MT
PRESTIGE CONSUMER HEALTHCARE : DA Davidson Adjusts Prestige Consumer Healthcare's Price Target to $61 from $52, Keeps Neutral Rating MT
PRESTIGE CONSUMER HEALTHCARE : DA Davidson Adjusts Prestige Consumer Healthcare's Price Target to $52 from $49, Keeps Neutral Rating MT
PRESTIGE CONSUMER HEALTHCARE : DA Davidson Adjusts Prestige Consumer Healthcare's Price Target to $49 from $39, Keeps Neutral Rating MT
PRESTIGE CONSUMER HEALTHCARE : DA Davidson Adjusts Prestige Consumer Healthcare's Price Target to $39 from $45, Maintains Neutral Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
68.28 USD
Average target price
78.17 USD
Spread / Average Target
+14.48%
High Price Target
93 USD
Spread / Highest target
+36.20%
Low Price Target
68 USD
Spread / Lowest Target
-0.41%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Prestige Consumer Healthcare Inc.

DA Davidson
Oppenheimer
Canaccord Genuity
Jefferies & Co.

Ratings for Prestige Consumer Healthcare Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PBH Stock
  4. Consensus Prestige Consumer Healthcare Inc.